NSCLC cells that do not express EGFR (H661, H520) or are resistant to gefitinib (H226) [11] did not exhibit FGFR2 and FGFR3 mRNA induction in response to gefitinib (Figure 1A). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.